AA
AGN

Apriem Advisors’s Allergan plc AGN Stock Holding History

Apriem Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,600
Closed -$460K – 125
2020
Q1 		$460K Hold
2,600
– – 0.11% 71
2019
Q4 		$497K Hold
2,600
– – 0.1% 80
2019
Q3 		$438K Hold
2,600
– – 0.1% 82
2019
Q2 		$435K Sell
2,600
-234
-8% -$32.4K 0.14% 85
2019
Q1 		$415K Sell
2,834
-39
-1% -$5.65K 0.11% 81
2018
Q4 		$384K Sell
2,873
-300
-9% -$49.2K 0.14% 81
2018
Q3 		$604K Buy
3,173
+100
+3% +$18.4K 0.13% 74
2018
Q2 		$512K Sell
3,073
-53
-2% -$8.51K 0.12% 75
2018
Q1 		$526K Sell
3,126
-217
-6% -$36.4K 0.13% 67
2017
Q4 		$547K Sell
3,343
-585
-15% -$105K 0.14% 65
2017
Q3 		$805K Buy
+3,928
New +$913K 0.2% 57
2017
Q2 		– Sell
-1,398
Closed -$334K – 609
2017
Q1 		$334K Buy
1,398
+356
+34% +$82.9K 0.09% 88
2016
Q4 		$219K Buy
1,042
+21
+2% +$4.35K 0.07% 118
2016
Q3 		$235K Buy
1,021
+12
+1% +$2.93K 0.07% 106
2016
Q2 		$233K Buy
1,009
+760
+305% +$175K 0.08% 107
2016
Q1 		$67K Hold
249
– – 0.03% 175
2015
Q4 		$78K Hold
249
– – 0.03% 159
2015
Q3 		$68K Hold
249
– – 0.03% 171
2015
Q2 		$76K Hold
249
– – 0.03% 168
2015
Q1 		$74K Buy
+249
New +$71K 0.03% 171

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Apriem Advisors's AGN Position: Q2 2020 in Review

Apriem Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,600 shares — an estimated $460K sold.

Apriem Advisors first reported a position in AGN in Q1 2015 and held it in 20 quarters. The position peaked at $805K in Q3 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Apriem Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Apriem Advisors sold 2,600 Allergan plc shares in Q2 2020, an estimated $460K.
  • Apriem Advisors first reported a position in Allergan plc in Q1 2015 and held it in 20 quarters.
  • Apriem Advisors's Allergan plc position peaked at $805K in Q3 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Apriem Advisors's 13F filing for Q2 2020, filed 7 Aug 2020.